Article Information
History
- September 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Paul R Barber‡,1,2,
- Fabian Flores-Borja‡,*,3,
- Giovanna Alfano‡,4,
- Kenrick Ng‡,1,
- Gregory Weitsman4,
- Luigi Dolcetti4,
- Rami Mustapha4,
- Felix Wong4,
- Jose M Vicencio1,4,
- Myria Galazi1,
- James W Opzoomer5,
- James N Arnold5,
- Shahram Kordasti6,
- Jana Doyle7,
- Jon Greenberg7,
- Magnus T Dillon8,
- Kevin J Harrington8,
- Martin D Forster1,
- Anthony C C Coolen9,10 and
- Tony Ng1,3,4,†
- 1UCL Cancer Institute, Paul O’Gorman Building, University College London, London, UK
- 2Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
- 3Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
- 4Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
- 5Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
- 6Systems Cancer Immunology, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
- 7Daichii Sankyo Incorporated, New Jersey, USA
- 8The Institute of Cancer Research, London, UK
- 9Institute for Mathematical and Molecular Biomedicine, King’s College London, UK
- 10Saddle Point Science Ltd, London, UK
- ↵†To whom correspondence should be addressed: Prof. Tony Ng
, Tel no: +44 (0) 20 7848 8056 (KCL), E-mail: tony.ng{at}kcl.ac.uk, t.ng{at}ucl.ac.uk
↵‡ These authors contributed equally to this work.
Posted September 23, 2021.
Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development
